EUVIMEDEUVIMED entdecken
Crossref

High prevalence of “non‐pathogenic” POLE mutation with poor prognosis in a cohort of endometrial cancer from South India

Santhosh Kuriakose iD, Dhananjayan Dhanasooraj iD, P M Shiny, S Shammy, V P Sona, Anupama A Manjula, Amrutha Ramachandran, Bindu Vijaykumar, Nayana Susan, M Dinesan, Uma V Sankar, Kavitha Ramachandran und 1 weitere

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.15486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Santhosh Kuriakose und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Government Medical College, Kozhikode, Kerala, India. Hauptthemen laut MEDLINE: Endometrial Neoplasms, DNA Polymerase II, Mutation, Poly-ADP-Ribose Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The Cancer Genome Atlas (TCGA) project identified favorable prognosis regarding the ultra‐mutated endometrial cancer (EC) subtype linked to polymerase epsilon gene (POLE) mutations. This study investigated POLE mutations in EC of Indian patients.

Methods

This retrospective analytical study was conducted between January 2016 and January 2023 at the Government Medical College, Kozhikode, and the MVR Cancer Center, Kozhikode, Kerala. Sanger sequencing of POLE gene exons 9 and 13 in 151 EC patients was carried out to analyze the relationship between mutations and epidemiological factors, clinicopathologic features, and treatment outcomes.

Results

Among 151 cases enrolled, 39 were unique POLE‐mutated cases. Significant associations were high‐grade tumors, myometrial invasion >50%, and Lymph‐vascular space invasion (LVSI). The median follow‐up was 40 months (95% confidence interval [CI], 34–46). A lower mean disease‐specific survival (DSS) of 51.7 months (95% CI, 43.7–59.6) was noted in the POLE‐mutated group compared with 72.11 months (95% CI, 67.60–76.62) for the POLE wild‐type. A statistically significant hazard ratio (HR) of 2.683 for DSS in the POLE‐mutated group was noted. In advanced stages (FIGO stages II–IV), a nine‐fold HR for DSS and overall survival (OS) compared with POLE wild‐type was identified. After controlling for treatment effects using Cox proportional HR, advanced‐stage POLE‐mutated tumors had a significantly higher HR of 8.67 for DSS compared with POLE‐wild‐type tumors of the same stage.

Conclusion

This study identified a unique set of POLE mutations in Indian EC patients associated with poor prognosis, which were particularly pronounced in advanced stages. Advanced stage of presentation, type of POLE mutations, and possibly ethnicity are predictors of adverse outcomes in POLE‐mutated EC. The present study highlights ethnicity as a determinant of phenotypic expression of genetic change.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsDNA Polymerase IIMutationPoly-ADP-Ribose Binding ProteinsHumansFemaleIndiaMiddle AgedRetrospective StudiesPrognosisAgedAdultPrevalenceNeoplasm Staging

Stichwörter der Autor:innen

POLE mutationSanger sequencingendometrial carcinomapolymerase epsilon (POLE) geneprognosis

Substanzen

DNA Polymerase IIPOLE protein, humanPoly-ADP-Ribose Binding Proteins

Autor:innen und Institutionen

  • Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Government Medical College, Kozhikode, Kerala, India.
  • Multidisciplinary Research Unit, Government Medical College, Kozhikode, Kerala, India.
  • Department of Pathology, Government Medical College, Kozhikode, Kerala, India.
  • Department of Obstetrics and Gynecology, Government Medical College, Kozhikode, Kerala, India.
  • Department of Radiation Oncology, Tertiary Cancer Care Center, Government Medical College, Kozhikode, Kerala, India.
  • MVR Cancer Centre & Research Institute, Kozhikode, Kerala, India.

ORCID-Profile: Santhosh Kuriakose, Dhananjayan Dhanasooraj

Förderung

  • Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India
  • Science and Engineering Research Board

Zitieren

APA

Kuriakose, S., Dhanasooraj, D., Shiny, P. M., Shammy, S., Sona, V. P., Manjula, A. A., Ramachandran, A., Vijaykumar, B., Susan, N., Dinesan, M., Sankar, U. V., Ramachandran, K., & Sreedharan, P. S. (2024). High prevalence of “non‐pathogenic” POLE mutation with poor prognosis in a cohort of endometrial cancer from South India. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15486

Vancouver

Kuriakose S, Dhanasooraj D, Shiny PM, Shammy S, Sona VP, Manjula AA, et al. High prevalence of “non‐pathogenic” POLE mutation with poor prognosis in a cohort of endometrial cancer from South India. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15486

BibTeX
@article{Kuriakose2024,
  author = {Kuriakose, Santhosh and Dhanasooraj, Dhananjayan and Shiny, P M and Shammy, S and Sona, V P and Manjula, Anupama A and Ramachandran, Amrutha and Vijaykumar, Bindu and Susan, Nayana and Dinesan, M and Sankar, Uma V and Ramachandran, Kavitha and Sreedharan, P S},
  title = {High prevalence of “non‐pathogenic” POLE mutation with poor prognosis in a cohort of endometrial cancer from South India},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.15486}
}
Kostenlos starten →